We are live on ! Find out more
SCS

Syquant Capital SAS Portfolio holdings

AUM $447M
1-Year Est. Return 13.04%
This Fund
S&P 500
This Quarter Est. Return
+42.66%
1 Year Est. Return
+13.04%
3 Year Est. Return
+175.6%
5 Year Est. Return
+350.63%
10 Year Est. Return
–
AUM
$22.2M
AUM Growth
-$233M
Cap. Flow
-$234M
Cap. Flow %
-1,056.59%
Top 10 Hldgs %
100%
Holding
15
New
7
Increased
–
Reduced
–
Closed
8

Top Buys

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$8.65M
2
LAZ icon
Lazard
LAZ
+$6.23M
3
ICVX
Icosavax, Inc. Common Stock
ICVX
+$1.84M
4
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$1.58M
5
FRO icon
Frontline
FRO
+$133K

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$162M
2
ATVI
Activision Blizzard
ATVI
+$71.5M
3
TWNK
Hostess Brands, Inc. Class A Common Stock
TWNK
+$6.1M
4
CPRI icon
Capri Holdings
CPRI
+$5.98M
5
NATI
National Instruments Corp
NATI
+$3.18M

Sector Composition

Rank Sector Weight
1 Healthcare 65.99%
2 Financials 32.48%
3 Technology 0.58%
4 Energy 0.58%
5 Consumer Discretionary 0.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$9.04M 40.81%
+153,920
New +$8.65M
LAZ icon
2
Lazard
LAZ
$4.25B
$7.2M 32.48%
+206,800
New +$6.23M
ICVX
3
DELISTED
Icosavax, Inc. Common Stock
ICVX
$3M 13.56%
+190,654
New +$1.84M
KRTX
4
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$2.57M 11.61%
+8,130
New +$1.58M
LOGI icon
5
Logitech
LOGI
$14.8B
$129K 0.58%
+1,363
New +$112K
FRO icon
6
Frontline
FRO
$8.12B
$128K 0.58%
+6,412
New +$133K
RACE icon
7
Ferrari
RACE
$66.3B
$82K 0.37%
+243
New +$81.1K
ARMK icon
8
Aramark
ARMK
$14.9B
– –
-47,460
Closed -$1.19M
CPRI icon
9
Capri Holdings
CPRI
$1.88B
– –
-113,582
Closed -$5.98M
PHIN icon
10
Phinia Inc
PHIN
$2.97B
– –
-29,599
Closed -$793K
SGEN
11
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-14,000
Closed -$2.19M
TWNK
12
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
– –
-183,050
Closed -$6.1M
NATI
13
DELISTED
National Instruments Corp
NATI
– –
-53,300
Closed -$3.18M
HZNP
14
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-1,398,990
Closed -$162M
ATVI
15
DELISTED
Activision Blizzard
ATVI
– –
-763,211
Closed -$71.5M

Similar funds

PT
Plimoth Trust Plymouth, Massachusetts $447M AUM 24.12% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $448M AUM 21.79% 1-Year Est. Return
PC
Peavine Capital Reno, Nevada $446M AUM 7.66% 1-Year Est. Return
AIS
American Investment Services Great Barrington, Massachusetts $448M AUM 21.7% 1-Year Est. Return
SCA
Stokes Capital Advisors Greenwood, South Carolina $446M AUM 13.55% 1-Year Est. Return
FTA
Financial & Tax Architects St Louis, Missouri $448M AUM 13.98% 1-Year Est. Return
GC
Guidance Capital Lousville, Kentucky $446M AUM 19.83% 1-Year Est. Return
POEH
Post Oak Energy Holdings Houston, Texas $449M AUM 53.94% 1-Year Est. Return

Syquant Capital SAS's Q4 2023 Portfolio in Review

As of Q4 2023, Syquant Capital SAS held 15 positions worth $22.2M, down 91% from $255M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Syquant Capital SAS withdrew a net $234M in Q4 2023, closing 8 positions. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $162M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, up from 64% a quarter earlier, followed by Financials and Technology.

Against the trend, Syquant Capital SAS opened a new position in Mirati Therapeutics, Inc. Common Stock worth $9.04M.

  • Syquant Capital SAS's largest Q4 2023 buy was Mirati Therapeutics, Inc. Common Stock: 153,920 shares worth $9.04M.
  • Syquant Capital SAS fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $162M.
  • Syquant Capital SAS's ten largest holdings make up 100% of its $22.2M portfolio in Q4 2023.
  • Syquant Capital SAS opened 7 new positions and closed 8 in Q4 2023.
  • Syquant Capital SAS's portfolio value fell 91% quarter-over-quarter to $22.2M.

Based on Syquant Capital SAS's 13F filing for Q4 2023, filed 10 Jan 2024.